Revenue | ₹0.05Cr |
Net Profits | ₹0.37Cr |
Net Profit Margins | -740.00% |
Transgene Biotek Ltd’s revenue fell -58.33% since last year same period to ₹0.05Cr in the Q3 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 0% jump in its revenue since last 3-months.
Transgene Biotek Ltd’s net profit fell -311.11% since last year same period to ₹0.37Cr in the Q3 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 5.13% jump in its net profits since last 3-months.
Transgene Biotek Ltd’s net profit margin fell -886.67% since last year same period to -740.00% in the Q3 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 5.13% jumped in its net profit margins since last 3-months.
The revenue for Transgene Biotek Ltd in the Q3 results 2025 was ₹0.05Cr.
The net profit for Transgene Biotek Ltd in the Q3 results 2025 was ₹0.37Cr.
The net profit margin for Transgene Biotek Ltd in the Q3 results 2025 was -740.00%.
The revenue for Transgene Biotek Ltd in the Q3 results 2024 was ₹0.12Cr.
The net profit for Transgene Biotek Ltd in the Q3 results 2024 was ₹0.09Cr.
The net profit margin for Transgene Biotek Ltd in the Q3 results 2024 was -75.00%.